Pseudomonas aeruginosa isolation in respiratory samples of children with neurological impairment- does it matter?

K. Wilkinson (Leicester, United Kingdom), R. Devaney (Leicester, United Kingdom), B. Elkington (Leicester, United Kingdom), I. Ahmed (Leicester, United Kingdom), H. Hickey (Leicester, United Kingdom), L. Mogford (Leicester, United Kingdom), A. Karthik (Leicester, United Kingdom), K. Jain (Leicester, United Kingdom)

Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Session: Acute and chronic lung infections in children
Session type: Oral Presentation
Number: 2843

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Wilkinson (Leicester, United Kingdom), R. Devaney (Leicester, United Kingdom), B. Elkington (Leicester, United Kingdom), I. Ahmed (Leicester, United Kingdom), H. Hickey (Leicester, United Kingdom), L. Mogford (Leicester, United Kingdom), A. Karthik (Leicester, United Kingdom), K. Jain (Leicester, United Kingdom). Pseudomonas aeruginosa isolation in respiratory samples of children with neurological impairment- does it matter?. 2843

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The clinical evaluation of patients with Pseudomonas aeruginosa detected in respiratory specimens
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012

Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Source: Eur Respir J 2014; 44: 794-797
Year: 2014


Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults.
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017

Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017



The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis
Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017
Year: 2018



Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010


Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection
Source: Eur Respir J 2005; 25: 911-914
Year: 2005



Respiratory infections caused by Pseudomonas aeruginosa in patients admitted in a respiratory care unit
Source: Eur Respir J 2005; 26: Suppl. 49, 187s
Year: 2005

Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 58s
Year: 2005

Training dogs to differentiate Pseudomonas aeruginosa from other cystic fibrosis bacterial pathogens: not to be sniffed at?
Source: Eur Respir J, 54 (5) 1900970; 10.1183/13993003.00970-2019
Year: 2019



The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006



Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010



Antibiotic-resistant bacteria in respiratory samples of children with severe neurological problems
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017
Year: 2018